INDEMNIFICATION AGREEMENTIndemnification Agreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • Delaware
THIS AGREEMENT is made as of November ___, 2004, by and among Prestwick Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and ___(the “Indemnitee”), a director of the Company.
PRESTWICK PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • Delaware
and AMENDED AND RESTATED AGREEMENTAgreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • England
February 25, 2004 Robert Whitehead c/o Prestwick Pharmaceuticals, Inc. 1825 K Street, NW, Suite 1475 Washington, D.C. 20006 Dear Bob:Prestwick Pharmaceuticals Inc • April 22nd, 2005 • District of Columbia
This letter sets forth the substance of the agreement (the “Agreement”) between you and Prestwick Pharmaceuticals, Inc., a Delaware corporation (the “Company”) regarding our mutual agreement that you separate from the Company.
Development and Commercialization License and Clinical Supply Agreement by and between NEUROBIOTEC GmbH and PRESTWICK Pharmaceuticals, Inc. 11 September 2003Prestwick Pharmaceuticals Inc • April 22nd, 2005
and AGREEMENT FOR CANADIAN RIGHTS TO NITOMANAgreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • England
ASSET PURCHASE AND SUBSCRIPTION AGREEMENTAsset Purchase and Subscription Agreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • Delaware
This Asset Purchase and Subscription Agreement (this “Agreement”) is entered into as of December 13, 2002, by and among Prestwick Scientific Capital, Inc., a Delaware corporation (“Assignor”), Prestwick Companies, Inc., a Delaware corporation (“PCI”), and KCS Pharmaceuticals, Inc., a Delaware corporation (“Assignee”).
LICENSE AGREEMENTLicense Agreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • Delaware
THIS AGREEMENT, effective as of June 2001, between DR. MAURICE W. GITTOS, residing at 16 rue Andre Malraux, 67115 Plobsheim, France (“LICENSOR”) and PRESTWICK SCIENTIFIC CAPITAL, INC., a Delaware corporation having offices at 1825 K Street, N.W., Washington, D.C. 20006 (“LICENSEE”).
LICENSE AGREEMENTLicense Agreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • Massachusetts
THIS AGREEMENT, effective as of October 6, 2000, (“EFFECTIVE DATE”) between THE GENERAL HOSPITAL CORPORATION, a not-for-profit corporation doing business as Massachusetts General Hospital, having a place of business at Fruit Street, Boston, Massachusetts 02114 (“GENERAL”) and PRESTWICK SCIENTIFIC CAPITAL, INC., a company having offices at 1825 K Street, N.W., Washington, D.C. 20006 (“COMPANY”).
Executive Employment AgreementExecutive Employment Agreement • April 22nd, 2005 • Prestwick Pharmaceuticals Inc • District of Columbia
This Executive Employment Agreement (“Agreement”) is entered into as of February 26, 2003 (the “Effective Date”), by and between Prestwick Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Kathleen Clarence-Smith, M.D., Ph.D. (the “Executive”).
